Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2015 | Adaptive licensing: A new approach for authorizing medicines

At the 20th Congress of the European Hematology Association (EHA), Stephen O’Brien, BSc (Hons), PhD, MBChB, FRCP, FRCPath, of the University of Newcastle, Newcastle upon Tyne, UK, explains the process of adaptive licensing of new medicines, which aims to improve timely access for patients to new medicines.